Insulin Pumps (External): Market Research Report

Date: January 11, 2016
Pages: 179
Price:
US$ 4,950.00
Publisher: Global Industry Analysts, Inc
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: IEBBE771102EN
Leaflet:

Download PDF Leaflet

Insulin Pumps (External): Market Research Report
This report analyzes the worldwide markets for Insulin Pumps (External) in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

The report profiles 15 companies including many key and niche players such as -
  • Animas Corp.
  • Debiotech S.A.
  • F. Hoffmann-La Roche, Ltd.
  • Insulet Corp.
  • Medtronic Plc
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

Insulin Pumps: A Prelude
The United States – The Largest Market
Europe – A Market with Vast Potential
Lower Current Penetration Leaves Significant Room for Growth

Table 1. Insulin Pumps Market by Region (2013): Percentage Breakdown of Number of Users of Insulin Pumps for Established Markets and Rest of World (includes corresponding Graph/Chart)
Table 2. Insulin Pump Penetration Rate in Type 1 Diabetic Patients by Country (2013): Number of Users as a Share of Population for Select Leading Countries (includes corresponding Graph/Chart)

Rising Incidence of Diabetes – A Major Market Driving Factor

Table 3. Global Diabetic Population by Region (2015 & 2040) (includes corresponding Graph/Chart)
Table 4. Top Ten Diabetic Countries by Number of Individuals with Diabetes for 2015 (includes corresponding Graph/Chart)
Table 5. Top Ten Diabetic Countries by Number of Individuals with Diabetes for 2040 (includes corresponding Graph/Chart)

Diabetes – Assessing the Economic Burden

Table 6. Diabetes Related Healthcare Expenditure by Region: 2015 & 2040 (in US$ Billion) (includes corresponding Graph/Chart)
Table 7. Major Spenders on Diabetes (2015): Annual Expenditure on Diabetes Treatment and Management in US$ Billion for Ten Leading Countries (includes corresponding Graph/Chart)

2. COMPETITIVE ANALYSIS

Insulin Pumps Market – Set for Interesting Road Ahead

Table 8. Leading Players in the Global Market for External Insulin Pumps (2015E): Percentage Breakdown of Value Sales for Insulet, J&J (Animas), Medtronic, Roche, Tandem and Others (includes corresponding Graph/Chart)

Comparison of Select Durable Insulin Pumps by Manufacturer
Medtronic Banks on New Solutions and Distribution Expansion to Retain Dominance
J&J’s OneTouch Via – A Discrete Solution for On-Demand Insulin
Tandem Sees Gradual Rise in Market Share
Ypsomed Eyes Brighter Prospects with YpsoPump
Medtrum – A New Entrant with a Strong Product; Threatening to Take the Market by Storm
Competitive Landscape in the Insulin Patch Pump Market
OmniPod Benefits from Lack of Close Competition in its League
Insulet Focuses on Advances in Technology and Services to Gain Market Share
Cellnovo’s Patch Pump Combines Functionality and Cost-Effectiveness
V-Go – An Affordable Patch Pump for Type II Diabetics
Valeritas Struggles to Push Sales of V-Go
Tough Ground for New Entrants

3. MARKET TRENDS AND ISSUES

Type II Diabetes – A Market with Significant Potential
Patch Pumps Gain Manufacturer Attention
Prefilled Insulin Cartridges Gain Popularity over Manual Filling
The Rise of Smart Pumps – A Major Game Changer
Innovative Features Spruce Up the Market for Insulin Pumps
Artificial Pancreas System (APS) – The Future of Diabetes Care
Artificial Pancreas – Are We There Yet?
The Risk of Diabetes in Aging Populace Presents Opportunities for Insulin Pumps

Table 9. Percentage Growth of 65+ Population in North America, Europe, Asia, and Latin America (includes corresponding Graph/Chart)
Table 10. Global Population Statistics for the 65+ Age Group (2015) (includes corresponding Graph/Chart)
Table 11. Comparison of Aging Population by Country (1980, 2015 & 2050): Percentage Share of Population Aged Above-65 Years of the Overall Population for Select Countries (includes corresponding Graph/Chart)
Table 12. Life Expectancy for Select Countries in Number of Years: 2015E (includes corresponding Graph/Chart)

Alarming Rise in Obesity – A Business Case for Diabetes Care

Table 13. World Obesity Prevalence (2015 & 2022): Percentage of Obese Population for Leading Ten Countries (includes corresponding Graph/Chart)

Diabetes in Developing Countries to Expand Opportunities

4. KEY MARKET DRIVERS AND CHALLENGES

ICR: A Key Factor to Success
Customer Satisfaction: Crucial to Stay Competitive
Expiry of Warranty Provides New Opportunities to Insulin Pump Makers
Undiagnosed Diabetes – A Key Challenge
Better Safety Review – A Growing Need for Insulin Pumps
Insulin Pump Training - Not Receiving Adequate Attention
Complicated Insulin Pump Software Makes Pump Use Difficult for the Aged
Competition from Other Insulin Delivery Technologies Continues
Implantable Insulin Pumps – A Potential Threat to External Insulin Pumps
Lantus: A Threat to Insulin Pump Manufacturers

5. DIABETES & INSULIN – AN ABSTRACT

Diabetes - A Fatal Disease
Risk Factors for Diabetes
Types of Diabetes
Long Term Complications of Diabetes
Testing Sugar Levels: Easy and Accurate
Insulin
Pancreas: The Main Source of Insulin in Human Body
Types of Insulin
Types of Insulin & Onset of Action
Goal of Insulin Therapy
Insulin Delivery Systems
a. Syringes
b. Insulin Pens
c. Jet Injectors
d. Tablets
e. External Insulin Pumps
f. Artificial Pancreas
Insulin Delivery Technologies

6. PRODUCT OVERVIEW

Evolution of Insulin Pumps
Components of Insulin Pump
How Does an Insulin Pump Work?
Value-added Features of Modern Insulin Pumps
Bolus Calculators
Insulin on Board
Customized Alarms
Touch Bolus
Interface to PCs
Others
Insulin Pump Delivery Rates
Guidelines for Insulin Pump Usage
Advantages
More Accurate and Consistent
Enhances Blood Sugar Control in Pediatric Patients
Adjusting Time Zones While Traveling
Improves Quality of Life
Patient Convenience
Other Advantages
Disadvantages/Risks Involved in the Usage of Insulin Pumps
High Cost
High Involvement
Diabetic Ketoacidosis Risk
Glucose Testing at Regular Intervals
Regular Rotation of Infusion Set
Carrying Back-up Kit
Regular Refilling of Pump
Other Disadvantages

7. PRODUCT INNOVATIONS/INTRODUCTIONS

Cellnovo Files FDA 510(k) Clearance for Diabetes Management System
Medtronic Obtains FDA Nod for its New MiniMed 670G System
Medtrum Launches Medtrum P6 Tubeless Insulin Pump
Medtronic Launches MiniMed 630G System
Tandem Secures FDA Expanded Indication for t:slim Insulin Pump
EMA Clears Use of mylife YpsoPump with NovoRapid PumpCart
Animas Receives FDA Expanded Indication for Animas Vibe Insulin Pump in Children
Medtronic Introduces MiniMed Connect System for Insulin Pumps and CGMs
Tandem Gets FDA Nod for t:slim G4 Insulin Pump
Unilife Rolls Out Instant Patch Pumps Platform - Imperium
Medtronic Rolls Out MiniMed 640G System
Tandem Bags FDA Clearance for t:flex Insulin Pump
Roche Rolls Out Accu-Chek Insight Insulin Pump System in the UK
J&J Animas Obtains FDA Approval for Vibe Insulin Pump
Novo Nordisk Launches NovoRapid PumpCart Prefilled Cartridge
Medtronic Introduces Arabic-Enabled Insulin Pump
Medtronic Launches MiniMed Duo in Europe
Animas Secures CE Mark for Animas Vibe Insulin Pump
Cellnovo Introduces Novel Insulin Pump System in the UK
Debiotech to Unveil JewelPump2
J&J Introduces Animas Vibe in Canada

8. RECENT INDUSTRY ACTIVITY

Tandem Announces Order Intake for t:slim X2 Insulin Pump
Bigfoot Secure FDA’s Clearance for Artificial Pancreas Trial
Tandem Inks Technology Licensing Deal with TypeZero
Ypsomed and Novo Nordisk Sign Pact for mylife YpsoPump
UnitedHealth Group Selects Medtronic As Exclusive Supplier of Insulin Pumps
Cellnovo and Roche Enter into Commercial Agreement for BGM
Insulet Inks Deal with Mode for Licensing Artificial Pancreas Algorithm
Ypsomed Expands Availability of mylife OmniPod in Europe
Medtronic Enters into Agreement with Chengdu Government to Produce Insulin Pumps
Insulet and Eli Lilly Team Up to Develop New Version of OmniPod for Delivering Lilly's Humalog
Tandem and Dexcom Ink Deal to Pair their Devices
BD Medical and Medtronic Collaborate to Launch New Infusion Set
Bigfoot Biomedical Takes Over Asante Solutions
Debiotech to Take Over Rights to iSense CGM
Medtronic Acquires Covidien

9. FOCUS ON SELECT PLAYERS

Animas Corp. (USA)
Debiotech S. A. (Switzerland)
F. Hoffmann-La Roche, Ltd. (Switzerland)
Insulet Corp. (USA)
Medtronic Plc. (Ireland)
Sooil Development Co. Ltd. (Korea)
Tandem Diabetes Care Inc. (USA)
Valeritas Inc. (US)
Ypsomed Holding AG (Switzerland)

10. GLOBAL MARKET PERSPECTIVE

Table 14. World Recent Past, Current & Future Analysis for Insulin Pumps (External) by Geographic Region - US, Canada, Europe, Asia-Pacific (Including Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 15. World Historic Review for Insulin Pumps (External) by Geographic Region - US, Canada, Europe, Asia-Pacific (Including Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 16. World 14-Year Perspective for Insulin Pumps (External) by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Europe, Asia-Pacific (Including Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

A. Market Analysis
Current & Future Analysis

Table 17. Prevalence of Diabetes Mellitus in the US (2013 & 2035): Number of People with DM (in Thousands) in the 20-79 Age Group (includes corresponding Graph/Chart)
Table 18. The US Diabetics Population (2010-2017): Percentage Population with Diagnosed and Undiagnosed Diabetes (includes corresponding Graph/Chart)
Table 19. US Market for Diabetes Management (2015 & 2018P): Percentage Share Breakdown by Treatment Type (includes corresponding Graph/Chart)
Table 20. Diabetes Prevalence by Ethnicity (includes corresponding Graph/Chart)

Increasing Inclination towards Patch Pumps
Artificial Pancreas System (APS): The Future of Diabetes Management
Select Clinical Studies on Artificial Pancreas Technology
Competitive Scenario

Table 21. Leading Players in the US Insulin Pump Market (2014): Percentage Breakdown of Installed Base by Company (includes corresponding Graph/Chart)

Comparison of Select Insulin Pump Systems Available in the US
Reimbursements
Regulatory Scenario
FDA Announces a New Mandate for Manufacturing Companies
Product Approvals/Launches
Strategic Corporate Developments
Select Key Players
B. Market Analytics

Table 22. The US Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 23. The US Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

2. CANADA

A. Market Analysis
Current & Future Analysis
Diabetes Statistics

Table 24. Prevalence of Adult Diabetes in Canada by Gender (2010-2014): Number of Adult Males and Females Aged 12 Years and Over Diagnosed with Diabetes (In Thousands) (includes corresponding Graph/Chart)
Table 25. Prevalence of Adult Diabetes in Canada by Age Group (2010-2014): Number of Adult Males and Females with Diabetes by Age Group (In Thousands) (includes corresponding Graph/Chart)

Product Launch
B. Market Analytics

Table 26. Canadian Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 27. Canadian Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

3. EUROPE

A. Market Analysis
Current & Future Analysis
Market Overview
Regional Scenario
Diabetes Prevalence in Europe

Table 28. Diabetes Prevalence in Europe (2015): Prevalence of Type I & Type II Diabetes As Percentage of Adult Population (Aged 20 to 79 Years) by Country (includes corresponding Graph/Chart)

Product Approvals
B. Market Analytics

Table 29. European Recent Past, Current & Future Analysis for Insulin Pumps (External) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 30. European Historic Review for Insulin Pumps (External) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 31. European 14-Year Perspective for Insulin Pumps (External) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

3A. FRANCE

A. Market Analysis
Current & Future Analysis
Strategic Corporate Development
B. Market Analytics

Table 32. French Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 33. French Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

3B. GERMANY

Market Analysis

Table 34. German Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 35. German Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

3C. ITALY

Market Analysis

Table 36. Italian Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 37. Italian Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

3D. THE UNITED KINGDOM

A. Market Analysis
Current & Future Analysis
INPUT (The Insulin Pump Therapy Group)
NICE (National Institute of Clinical Excellence)
Product Launches
B. Market Analytics

Table 38. The UK Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 39. The UK Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

3E. SPAIN

Market Analysis

Table 40. Spanish Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 41. Spanish Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

3F. RUSSIA

Market Analysis

Table 42. Russian Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 43. Russian Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

3G. REST OF EUROPE

A. Market Analysis
Current & Future Analysis
Diabetes in Russia
Product Launches
Strategic Corporate Developments
Select Key Players
B. Market Analytics

Table 44. Rest of European Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 45. Rest of European Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

4. ASIA-PACIFIC

A. Market Analysis
Current & Future Analysis

Table 46. Diabetes in Asia-Pacific (2015): Number of People with Diabetes for Select Countries (includes corresponding Graph/Chart)

Review of Select Markets
China
Overview
China: An Untapped Goldmine
India
Diabetes Scenario
Insulin Pumps Market in India – An Overview
New Indigenously Developed Product Could be the Answer
Medtronic: The Current Market Leader
Diabetic Epidemic Spurs Indian Market
Strategic Corporate Development
Key Player
B. Market Analytics

Table 47. Asia-Pacific Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 48. Asia-Pacific Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

5. LATIN AMERICA

A. Market Analysis
Current & Future Analysis
A Peek in to the Brazilian Insulin Pumps Market
B. Market Analytics

Table 49. Latin American Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 50. Latin American Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

6. REST OF WORLD

A. Market Analysis
Current & Future Analysis
Demand for Insulin Pumps Surges in the UAE
B. Market Analytics

Table 51. Rest of World Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 52. Rest of World Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 15 (including Divisions/Subsidiaries - 18)
The United States (11)
Europe (6)
  France (1)
  The United Kingdom (1)
  Rest of Europe (4)
Asia-Pacific (Excluding Japan) (1)
Skip to top


Insulin Delivery Systems: Market Research Report US$ 3,950.00 Apr, 2010 · 435 pages

Ask Your Question

Insulin Pumps (External): Market Research Report
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: